Article
<i>In Vivo</i> Biocompatibility of ZIF-8 for Slow Release via Intranasal Administration
2023-01-08
Abstract excerpt
Zeolitic Imidazolate Framework-8 (ZIF-8) is becoming popular in research for its potential in antigen protection and for providing a thermally stable, slow-release platform. While papers applying these materials for immunological applications are aplenty in literature, studies that explore the biosafety of ZIF-8 in mammals—especially when administered intranasally—are not well represented. We checked the body clea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6091ccc8-c638-5df6-b4e8-499497d1f1aa
- DOI
- 10.1101/2023.01.07.523104
